EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy

Monika Ryba-Stanisławowska iD

Cellular Oncology · 2025-04 · 48 (2) · 295-312

DOI: 10.1007/s13402-024-00992-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 26.09.2024. Verfasst von Monika Ryba-Stanisławowska. Beteiligte Einrichtung: Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, Gdańsk, 80-211, Poland. monika.ryba-stanislawowska@gu…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, T-Lymphocytes, Helper-Inducer, T-Lymphocyte Subsets. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T helper (Th) cell subsets play pivotal roles in regulating immune responses within the tumor microenvironment, influencing both tumor progression and anti-tumor immunity. Among these subsets, Th1 cells promote cytotoxic responses through the production of IFN-γ, while Th2 cells and regulatory T cells (Tregs) exert immunosuppressive effects that support tumor growth. Th9 and Th17 cells have context-dependent roles, contributing to both pro-inflammatory and regulatory processes in tumor immunity. Tumor antigen-specific T cells within the tumor microenvironment often exhibit a dysfunctional phenotype due to increased expression of inhibitory receptors such as CTLA-4 and PD-1, leading to reduced antitumor activity. Monoclonal antibodies that block these inhibitory signals—collectively known as immune checkpoint inhibitors (ICIs)—can reactivate these T cells, enhancing their ability to target and destroy cancer cells. Recent advancements have highlighted the critical role of T helper subsets in modulating responses to ICIs, with their interactions remaining a focus of ongoing research. Both positive and negative effects of ICIs have been reported in relation to Th cell subsets, with some effects depending on the type of tumor microenvironment. This review summarizes the crucial roles of different T helper cell subsets in tumor immunity and their complex relationship with immune checkpoint inhibitor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsHumansTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

Anti-CTLA-4Anti-PD1ICITh subsetsTumor immunity

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, Gdańsk, 80-211, Poland. monika.ryba-stanislawowska@gumed.edu.pl.

ORCID-Profile: Monika Ryba-Stanisławowska

Zitieren

APA

Ryba-Stanisławowska, M. (2025). Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy. Cellular Oncology, 48(2), 295-312. https://doi.org/10.1007/s13402-024-00992-0

Vancouver

Ryba-Stanisławowska M. Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy. Cellular Oncology. 2025;48(2):295-312. doi:10.1007/s13402-024-00992-0

BibTeX
@article{RybaStanisawowska2025,
  author = {Ryba-Stanisławowska, Monika},
  title = {Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {2},
  pages = {295--312},
  doi = {10.1007/s13402-024-00992-0}
}
Kostenlos starten →